Dreams to Reality: Journey of a Leader in Biopharma with Dr. Laxmi Adhikary

(11:43)

Full Japan lecture uncut (English)

(50:6)

Webinar: Advanced Analytical Characterization Technique for Biopharmaceutical Development | Veeda

(1:13:30)

MAGA Tries To Take On Katie Porter... INSTANTLY Regret It, Best Of 2024

(1:58:44)

Forensic Entomology \u0026 Decomposition 🪰 Benecke \u0026 Buttgereit: 'Schweinchen' (Piglets)

(18:35)

Neulasta

(3:6)

BIOSIMILARS -- a virtual discussion at MS Symposium Alabama

(18:39)

How Biosimilars Are Developed and Tested

(44)

Career in Pharma \u0026 Medicine Industry: Insights by Sachin Kumbhoje Part 1

(37:20)

6 Steps to Addressing Mold Toxicity

(4:1econd)

KSOS2024 GP1 3 Pearls for Retina Practice. Learn from Masters

(56:8)

Acalabrutinib, umbralisib \u0026 ublituximab (AU2) regimen in patients with de novo MCL

(2:2)

A study of ivosidenib with venetoclax ± azacitidine in IDH1-mutated hematologic malignancies

(1:33)

Briquilimab-based conditioning for patients with Fanconi anemia receiving alloSCT

(2:2)

The potential of combining BTKis with immunotherapies to treat R/R MCL

(3:5)

December 2024 FDA New Drug Approvals: Symvess for Surgical Vascular Implantation

(31)

Phase II RESTORE trial: elritercept as monotherapy \u0026 in combination with ruxolitinib in pts with MF

(5:19)

Updates in liquid biopsy and biomarker development at SABCS 2024

(42)